BiotechTube

Rabies + Japanese Encephalitis

Phase 3Completed
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rabies

Conditions

Rabies, Japanese Encephalitis

Trial Timeline

Aug 1, 2012 → Oct 1, 2013

NCT ID
NCT01662440

About Rabies + Japanese Encephalitis

Rabies + Japanese Encephalitis is a phase 3 stage product being developed by Novartis for Rabies. The current trial status is completed. This product is registered under clinical trial identifier NCT01662440. Target conditions include Rabies, Japanese Encephalitis.

What happened to similar drugs?

2 of 14 similar drugs in Rabies were approved

Approved (2) Terminated (0) Active (12)
🔄Abbreviated Zagreb 2-1-1 schedule + Standard Essen 1-1-1-1-1 scheduleNovartisPhase 3
🔄Rabies vaccine + Rabies vaccines + Rabies immunoglobulins + Rabies vaccine + Rabies vaccines + Rabies immunoglobulinsNovartisPhase 3
🔄Zagreb + EssenNovartisPhase 3
🔄rabies vaccineNovartisPhase 3
✅Purified Chick Embryo Cell Inactivated Rabies VaccineNovartisApproved
🔄Purified vero rabies vaccine - serum free + Purified inactivated rabies vaccine + Human rabies immunoglobulinsSanofiPhase 3
🔄VRVg-2 + Purified Inactivated Rabies Vaccine + Human Diploid Cell Vaccine (HDCV) + Rabies immune globulin (human)SanofiPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01662440Phase 3Completed

Competing Products

20 competing products in Rabies

See all competitors
ProductCompanyStageHype Score
Abbreviated Zagreb 2-1-1 schedule + Standard Essen 1-1-1-1-1 scheduleNovartisPhase 3
40
Three 1 mL doses of Rabies vaccine and two JE vaccine + Three 0.5 mL doses of Rabies vaccine and two JE vaccine + Three 0.1mL doses of Rabies Vaccine and two JE vaccine + Two 0.1mL doses of Rabies vaccine and two JE vaccine + Two doses of JE vaccineNovartisPhase 2
35
Rabies vaccine + Rabies vaccines + Rabies immunoglobulins + Rabies vaccine + Rabies vaccines + Rabies immunoglobulinsNovartisPhase 3
40
Zagreb + EssenNovartisPhase 3
40
rabies vaccineNovartisPhase 3
40
Purified Chick Embryo Cell Inactivated Rabies VaccineNovartisApproved
43
Intramuscular (IM) rabies post-exposure prophylaxis + Intradermal (ID) rabies post-exposure prophylaxisSanofiPre-clinical
26
Purified vero rabies vaccine - serum free + Purified inactivated rabies vaccine + Human rabies immunoglobulinsSanofiPhase 3
40
VRVg-2 + Purified Inactivated Rabies Vaccine + Human Diploid Cell Vaccine (HDCV) + Rabies immune globulin (human)SanofiPhase 3
40
Purified vero rabies vaccine - serum free - VRVg-2 + Purified inactivated rabies vaccine - Verorab® + Purified inactivated rabies vaccine - Imovax® RabiesSanofiPhase 3
40
HDCV + HDCV + PVRV + PVRVSanofiPhase 3
40
Purified Vero Rabies Vaccine (VRVg) - Serum Free + Imovax® Rabies: inactivated rabies vaccineSanofiPhase 2
35
Purified inactivated rabies vaccine, serum free + Purified inactivated rabies vaccine, serum free + Purified Vero Rabies Vaccine + Purified Vero Rabies VaccineSanofiPhase 3
40
Purified Vero Rabies Vaccine Serum Free (VRVg) + Imovax® Rabies: Human Diploid Cell Vaccine (HDCV),SanofiPhase 2
35
Purified vero rabies vaccine - serum free VRVg-2 + Purified inactivated rabies vaccine + Equine rabies immunoglobulins (ERIG) (only Group 3 and Group 4) + Human rabies immunoglobulins (HRIG) (only Group 5 and Group 6)SanofiPhase 3
40
Purified Vero Rabies Vaccine (VRVg) + Imovax® Rabies: inactivated rabies vaccineSanofiPhase 2
35
Purified Verocell Rabies Vaccine + Purified Verocell Rabies Vaccine + Purified Verocell Rabies VaccineSanofiApproved
43
VRVg 2 + VRVg 1 + Imovax Rabies + VRVg 2 + VRVg 2 + Human Rabies Immunoglobulins (HRIG)SanofiPhase 2
35
Purified Vero Rabies Vaccine - Serum Free + Purified inactivated rabies vaccineSanofiPhase 2
35
PVRV + PVRV and pERIG Favirab® + PVRV and pERIG Favirab®SanofiPhase 3
40